Skip to main content
Premium Trial:

Request an Annual Quote

ABI: Expression Array Formal Launch Likely in January

Premium

Applied Biosystems’ said this week that its Expression Array System, a whole-genome microarray, would likely be launched in January.

“The Expression Array System is currently under evaluation with customer test sites and we anticipate making the formal commercial launch announcement in January,” Lori Murray, an ABI spokeswoman, wrote in an email to BioArray News.

When the company announced in July it was launching this whole-genome microarray, it said the product would be launched by the end of the year. The decision for likely launch in January is not necessarily indicative of a delay in readying the product for the market: late December is not the optimum time for a product launch, according to the company.

ABI displayed the product at Chips to Hits in October. [For details on the product and the announcement, see BAN 11-05-03, 07-30-03]

The Expression Array System is to incorporate 60-mer oligonucleotides, as well as a chemiluminescent detection system for hybridization. It will also be packaged with a microarray analyzer, a database of gene and protein information, and reagents, the company has said.

— MMJ

 

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.